Marcain Polyamp Steripack 0.5%
- Name:
Marcain Polyamp Steripack 0.5%
- Company:
Aspen
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 20/09/17

XPIL
Package leaflet: Information for the user
Package leaflet: Information for the user
1. What Marcain Polyamp Steripack is and what it is used for
1. What Marcain Polyamp Steripack is and what it is used for
2. What you need to know before Marcain Polyamp Steripack is given to you
2. What you need to know before Marcain Polyamp Steripack is given to you
3. How Marcain Polyamp Steripack is given to you
3. How Marcain Polyamp Steripack is given to you
4. Possible side effects
4. Possible side effects
5. How to store Marcain Polyamp Steripack
5. How to store Marcain Polyamp Steripack
6. Contents of the pack and other information
6. Contents of the pack and other information

Print ViewKeyword Search SPC
1. NAME OF THE MEDICINAL PRODUCT
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4. CLINICAL PARTICULARS
5. PHARMACOLOGICAL PROPERTIES
5. PHARMACOLOGICAL PROPERTIES
6. PHARMACEUTICAL PARTICULARS
6. PHARMACEUTICAL PARTICULARS
7. MARKETING AUTHORISATION HOLDER
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
10. DATE OF REVISION OF THE TEXT
Aspen

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 21 September 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 September 2017 SPC
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Text in red = new text
Text strikethrough = deleted text
6.6 Special precautions for disposal of a used medicinal product or waste materials derived from such medicinal product and other handling of the product
Marketing Authorisation holder
Aspen Pharma Trading Limited,
3016 Lake Drive,
Citywest Business Campus,
Dublin 24,
Ireland.
AstraZeneca UK Ltd.,
600 Capability Green,
Luton,
Marketing authorisation number(s)
PA 1691/024/002
PA 970/45/2
Date of revision of the text
September 2017
21 Oct 2016
Updated on 20 September 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 20 September 2017 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 8 November 2016 SPC
Reasons for updating
- New individual SPC (was previously included in combined SPC)
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 4.2: editorial update to dosage recommendation for children table.
Section 4.4: updated with information in relation to hypotension and bradycardia.
Section 10: updated date of revision
Updated on 8 June 2015 PIL
Reasons for updating
- Change to date of revision
- Change to improve clarity and readability
- Addition of information on reporting a side effect.
Updated on 29 August 2013 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
- Change to dosage and administration
- Addition of information on reporting a side effect.
Updated on 4 November 2011 PIL
Reasons for updating
- Change to storage instructions
- Change to further information section
- Change to date of revision
- Introduction of new pack/pack size
Updated on 22 April 2010 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change due to user-testing of patient information
Updated on 25 July 2006 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to instructions about overdose
- Change to side-effects
- Change to date of revision
Updated on 24 October 2005 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
- Change to instructions about overdose
- Change to drug interactions
- Change to information about driving or using machinery
- Change to date of revision
- Change to information about pregnancy or lactation
- Change to dosage and administration
Updated on 28 July 2004 PIL
Reasons for updating
- New PIL for medicines.ie